organization · Reporting owner
Radius Venture Partners III, LLC
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TACTILE SYSTEMS TECHNOLOGY INC
Report date September 15, 2017 · Filed September 15, 2017
Jointly reported with RADIUS VENTURE PARTNERS III L P, Radius Venture Partners III QP, L.P., Radius Venture Partners III (OHIO), LP, LUBIN DANIEL C
Section 16 reporting ended · disclosed 2017-09-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Radius Venture Partners III, LP | 75,396 |
Reported balance
After 2017-09-15 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2017-09-15 · Sale · Disposed 75,373 · Balance 75,396 F1: Represents public offering price of $33.00 per common share less the underwriter's discount of $1.98 per common share. F2: These securities are held directly by Radius Venture Partners III, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Davis is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Radius Venture Partners III QP, LP | 822,147 |
Reported balance
After 2017-09-15 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2017-09-15 · Sale · Disposed 821,902 · Balance 822,147 F1: Represents public offering price of $33.00 per common share less the underwriter's discount of $1.98 per common share. F3: These securities are held directly by Radius Venture Partners III QP, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Davis is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Radius Venture Partners III (Ohio) LP | 103,255 |
Reported balance
After 2017-09-15 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2017-09-15 · Sale · Disposed 103,225 · Balance 103,255 F1: Represents public offering price of $33.00 per common share less the underwriter's discount of $1.98 per common share. F4: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Davis is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents public offering price of $33.00 per common share less the underwriter's discount of $1.98 per common share.
F2: These securities are held directly by Radius Venture Partners III, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Davis is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein.
F3: These securities are held directly by Radius Venture Partners III QP, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Davis is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein.
F4: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Davis is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein.
Tabula Rasa HealthCare, Inc.
Report date December 08, 2017 · Filed December 12, 2017
Jointly reported with RADIUS VENTURE PARTNERS III L P, Radius Venture Partners III QP, L.P., Radius Venture Partners III (OHIO), LP, Davis Jordan
Section 16 reporting ended · disclosed 2017-12-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Radius Venture Partners III (Ohio), L.P. | 121,717 |
Last balance in matching sequence
After 2017-12-11 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2017-12-08 · Sale · Disposed 51,896 · Balance 137,605 F1: Represents shares of the issuer's common stock sold in an underwritten public offering completed on December 8, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F3: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III (Ohio), L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Row 4 · 2017-12-11 · Sale · Disposed 15,888 · Balance 121,717 F2: Represents shares of the issuer's common stock sold upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F3: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III (Ohio), L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Radius Venture Partners III QP, L.P. | 969,144 |
Last balance in matching sequence
After 2017-12-11 transaction · row 5
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 2 · 2017-12-08 · Sale · Disposed 413,210 · Balance 1,095,654 F1: Represents shares of the issuer's common stock sold in an underwritten public offering completed on December 8, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F4: These securities are held directly by Radius Venture Partners III QP, L.P and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III QP, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Row 5 · 2017-12-11 · Sale · Disposed 126,510 · Balance 969,144 F2: Represents shares of the issuer's common stock sold upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F4: These securities are held directly by Radius Venture Partners III QP, L.P and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III QP, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Radius Venture Partners III, L.P. | 88,875 |
Last balance in matching sequence
After 2017-12-11 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 3 · 2017-12-08 · Sale · Disposed 37,984 · Balance 100,477 F1: Represents shares of the issuer's common stock sold in an underwritten public offering completed on December 8, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F5: These securities are held directly by Radius Venture Partners III, L.P., and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Row 6 · 2017-12-11 · Sale · Disposed 11,602 · Balance 88,875 F2: Represents shares of the issuer's common stock sold upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F5: These securities are held directly by Radius Venture Partners III, L.P., and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of the issuer's common stock sold in an underwritten public offering completed on December 8, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share.
F2: Represents shares of the issuer's common stock sold upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share.
F3: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III (Ohio), L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein.
F4: These securities are held directly by Radius Venture Partners III QP, L.P and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III QP, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein.
F5: These securities are held directly by Radius Venture Partners III, L.P., and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 11, 2017 Filed Dec 12, 2017 19:00 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 11,602 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-015268 · edgar.xml · nonDerivative · entry 6 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III, L.P. Disclosed balance after: 88,875 F2 · price: Represents shares of the issuer's common stock sold upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F5 · ownership.nature: These securities are held directly by Radius Venture Partners III, L.P., and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 11, 2017 Filed Dec 12, 2017 19:00 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 126,510 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-015268 · edgar.xml · nonDerivative · entry 5 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, L.P. Disclosed balance after: 969,144 F2 · price: Represents shares of the issuer's common stock sold upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F4 · ownership.nature: These securities are held directly by Radius Venture Partners III QP, L.P and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III QP, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 11, 2017 Filed Dec 12, 2017 19:00 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 15,888 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-015268 · edgar.xml · nonDerivative · entry 4 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), L.P. Disclosed balance after: 121,717 F2 · price: Represents shares of the issuer's common stock sold upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F3 · ownership.nature: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III (Ohio), L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 08, 2017 Filed Dec 12, 2017 19:00 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 37,984 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-015268 · edgar.xml · nonDerivative · entry 3 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III, L.P. Disclosed balance after: 100,477 F1 · price: Represents shares of the issuer's common stock sold in an underwritten public offering completed on December 8, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F5 · ownership.nature: These securities are held directly by Radius Venture Partners III, L.P., and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 08, 2017 Filed Dec 12, 2017 19:00 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 413,210 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-015268 · edgar.xml · nonDerivative · entry 2 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, L.P. Disclosed balance after: 1,095,654 F1 · price: Represents shares of the issuer's common stock sold in an underwritten public offering completed on December 8, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F4 · ownership.nature: These securities are held directly by Radius Venture Partners III QP, L.P and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III QP, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 08, 2017 Filed Dec 12, 2017 19:00 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 51,896 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-015268 · edgar.xml · nonDerivative · entry 1 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), L.P. Disclosed balance after: 137,605 F1 · price: Represents shares of the issuer's common stock sold in an underwritten public offering completed on December 8, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F3 · ownership.nature: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III (Ohio), L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 20:30 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 103,225 | $31.02 | $3,202,039.50 |
DisclosureSEC source: 0001144204-17-048267 · v475288_form4.xml · nonDerivative · entry 3 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner LUBIN DANIEL C · CIK 0001335280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio) LP Disclosed balance after: 103,255 F1 · price: Represents public offering price of $33.00 per common share less the underwriter's discount of $1.98 per common share. F4 · ownership.nature: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Davis is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 20:30 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 821,902 | $31.02 | $25,495,400.04 |
DisclosureSEC source: 0001144204-17-048267 · v475288_form4.xml · nonDerivative · entry 2 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner LUBIN DANIEL C · CIK 0001335280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, LP Disclosed balance after: 822,147 F1 · price: Represents public offering price of $33.00 per common share less the underwriter's discount of $1.98 per common share. F3 · ownership.nature: These securities are held directly by Radius Venture Partners III QP, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Davis is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 20:30 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 75,373 | $31.02 | $2,338,070.46 |
DisclosureSEC source: 0001144204-17-048267 · v475288_form4.xml · nonDerivative · entry 1 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner LUBIN DANIEL C · CIK 0001335280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III, LP Disclosed balance after: 75,396 F1 · price: Represents public offering price of $33.00 per common share less the underwriter's discount of $1.98 per common share. F2 · ownership.nature: These securities are held directly by Radius Venture Partners III, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Davis is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionSeries B Preferred Stock · Derivative | 197,846 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · derivative · entry 12 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III, L.P. Disclosed balance after: 0 Underlying: Common Stock · 101,982 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · derivative.exercise_date: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F5 · derivative.expiration_date: The securities did not have an expiration date. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionSeries B Preferred Stock · Derivative | 2,157,390 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · derivative · entry 11 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, L.P. Disclosed balance after: 0 Underlying: Common Stock · 1,112,056 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · derivative.exercise_date: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F5 · derivative.expiration_date: The securities did not have an expiration date. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionSeries B Preferred Stock · Derivative | 270,952 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · derivative · entry 10 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), L.P. Disclosed balance after: 0 Underlying: Common Stock · 139,665 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · derivative.exercise_date: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F5 · derivative.expiration_date: The securities did not have an expiration date. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionSeries A-1 Preferred Stock · Derivative | 21,428 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · derivative · entry 9 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III, L.P. Disclosed balance after: 0 Underlying: Common Stock · 11,045 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · derivative.exercise_date: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F5 · derivative.expiration_date: The securities did not have an expiration date. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionSeries A-1 Preferred Stock · Derivative | 233,659 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · derivative · entry 8 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, L.P. Disclosed balance after: 0 Underlying: Common Stock · 120,443 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · derivative.exercise_date: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F5 · derivative.expiration_date: The securities did not have an expiration date. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionSeries A-1 Preferred Stock · Derivative | 29,346 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · derivative · entry 7 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), L.P. Disclosed balance after: 0 Underlying: Common Stock · 15,127 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · derivative.exercise_date: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F5 · derivative.expiration_date: The securities did not have an expiration date. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | OtherCommon Stock | 1,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · nonDerivative · entry 6 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III, L.P. Disclosed balance after: 138,371 F6 · kind: 20,372 shares of common stock were surrendered to the Issuer at the completion of Issuer's initial public offering pursuant to the letter agreement, dated as of June 30, 2014, as amended, with the Issuer. F3 · ownership.nature: These securities are held directly by Radius Venture Partners III, L.P., and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | OtherCommon Stock | 16,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · nonDerivative · entry 5 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, L.P. Disclosed balance after: 1,508,864 F6 · kind: 20,372 shares of common stock were surrendered to the Issuer at the completion of Issuer's initial public offering pursuant to the letter agreement, dated as of June 30, 2014, as amended, with the Issuer. F2 · ownership.nature: These securities are held directly by Radius Venture Partners III QP, L.P and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III QP, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | OtherCommon Stock | 2,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · nonDerivative · entry 4 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), L.P. Disclosed balance after: 189,501 F6 · kind: 20,372 shares of common stock were surrendered to the Issuer at the completion of Issuer's initial public offering pursuant to the letter agreement, dated as of June 30, 2014, as amended, with the Issuer. F1 · ownership.nature: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III (Ohio), L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionCommon Stock | 113,027 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · nonDerivative · entry 3 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III, L.P. Disclosed balance after: 139,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F3 · ownership.nature: These securities are held directly by Radius Venture Partners III, L.P., and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionCommon Stock | 1,232,499 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · nonDerivative · entry 2 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, L.P. Disclosed balance after: 1,525,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F2 · ownership.nature: These securities are held directly by Radius Venture Partners III QP, L.P and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III QP, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionCommon Stock | 154,792 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · nonDerivative · entry 1 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), L.P. Disclosed balance after: 191,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F1 · ownership.nature: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III (Ohio), L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.